| 1 | CRABP2, MX1, SLC15A3 |
| Epigenetic silencing of CRABP2 and MX1 in head and neck tumors. | |
| Calmon MF, Rodrigues RV, Kaneto CM, Moura RP, Silva SD, Mota LD, Pinheiro DG, Torres C, de Carvalho AF, Cury PM, Nunes FD, Nishimoto IN, Soares FA, da Silva AM, Kowalski LP, Brentani H, Zanelli CF, Silva WA Jr, Rahal P, Tajara EH, Carraro DM, Camargo AA, Valentini SR. | |
| Neoplasia 11(12):1329-39.PMID: 20019841 2009 | |
| 2 | SLC15A3 |
| The proton oligopeptide cotransporter family SLC15 in physiology and pharmacology. | |
| Daniel H, Kottra G. | |
| Pflugers Arch 447(5):610-8. Epub 2003 Aug 7. Review. 2004 | |
| 3 | SLC15A3 |
| Cloning of a lymphatic peptide/histidine transporter. | |
| Sakata K, Yamashita T, Maeda M, Moriyama Y, Shimada S, Tohyama M. | |
| Biochem J 356(Pt 1):53-60. 2001 | |
| 4 | SLC15A3, SLC15A4 |
| Human proton/oligopeptide transporter (POT) genes: identification of putative human genes using bioinformatics. | |
| Botka CW, Wittig TW, Graul RC, Nielsen CU, Higaka K, Amidon GL, Sadee W. | |
| AAPS PharmSci 2(2):E16. 2000 | |